Dema, Emily; Sonnenberg, Pam; Gibbs, Jo; Conolly, Anne; Willis, Malachi; Riddell, Julie; Bosó Pérez, Raquel; Copas, Andrew J; Tanton, Clare; Bonell, Chris; +6 more... Oeser, Clarissa; Clifton, Soazig; Unemo, Magnus; Mercer, Catherine H; Mitchell, Kirstin R; Field, Nigel; (2022) How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID). Sexually Transmitted Infections, 99 (4). pp. 261-267. ISSN 1368-4973 DOI: https://doi.org/10.1136/sextrans-2022-055516
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Abstract
OBJECTIVES: To investigate how differential access to key interventions to reduce STIs, HIV and their sequelae changed during the COVID-19 pandemic. METHODS: British participants (18-59 years) completed a cross-sectional web survey 1 year (March-April 2021) after the initial lockdown in Britain. Quota-based sampling and weighting resulted in a quasi-representative population sample. We compared Natsal-COVID data with Natsal-3, a household-based probability sample cross-sectional survey (16-74 years) conducted in 2010-2012. Reported unmet need for condoms because of the pandemic and uptake of chlamydia testing/HIV testing/cervical cancer screening were analysed among sexually experienced participants (18-44 years) (n=3869, Natsal-COVID; n=8551, Natsal-3). ORs adjusted for age and other potential confounders describe associations with demographic and behavioural factors. RESULTS: In 2021, 6.9% of women and 16.2% of men reported unmet need for condoms because of the pandemic. This was more likely among participants: aged 18-24 years, of black or black British ethnicity, and reporting same-sex sex (past 5 years) or one or more new relationships (past year). Chlamydia and HIV testing were more commonly reported by younger participants, those reporting condomless sex with new sexual partners and men reporting same-sex partners; a very similar distribution to 10 years previously (Natsal-3). However, there were differences during the pandemic, including stronger associations with chlamydia testing for men reporting same-sex partners; with HIV testing for women reporting new sexual partners and with cervical screening among smokers. CONCLUSIONS: Our study suggests differential access to key primary and secondary STI/HIV prevention interventions continued during the first year of the COVID-19 pandemic. However, there was not strong evidence that differential access has changed during the pandemic when compared with 2010-2012. While the pandemic might not have exacerbated inequalities in access to primary and secondary prevention, it is clear that large inequalities persisted, typically among those at greatest STI/HIV risk.
Item Type | Article |
---|---|
Faculty and Department | Faculty of Public Health and Policy > Public Health, Environments and Society |
Research Centre |
Covid-19 Research Clinical Trials Unit |
PubMed ID | 35981863 |
Elements ID | 182653 |
Download
Filename: Dema_etal_2022_How-did-the-covid-19.pdf
Licence: Creative Commons: Attribution 4.0
Download